Vaccination News

An FDA advisory committee on Tuesday unanimously backed Moderna’s COVID-19 vaccines for children and adolescents aged 6 to 17 years.

Last week, an FDA advisory committee voted 21-0, with one abstention, to recommend granting emergency use authorization to Novavax’s two-dose COVID-19 vaccine for adults.

War has increased the risk for polio in Ukraine and beyond, interrupting health resources in a country with low immunization rates that has experienced recent vaccine-derived polio outbreaks, experts said at ASM Microbe.

For patients with HF, COVID-19 vaccination was associated with lower risk for hospitalization, ICU admission or death compared with those partially or unvaccinated, researchers reported.

Moderna said Wednesday that its bivalent COVID-19 vaccine booster candidate elicited a superior antibody response against the omicron variant of SARS-CoV-2 compared with the original vaccine.

Telemedicine offers the promise of increased efficiency during patient care, but in-person evaluations and relationships are too valuable to completely disregard, according to a debate session at EULAR 2022 Congress.

An FDA advisory committee on Tuesday recommended that Novavax’s two-dose COVID-19 vaccine be made available in the United States under an emergency use authorization.

As the monkeypox case count climbs in the United States, experts warned about the consequences of stigmatizing language, which could discourage patients from seeking treatment.

The resolution of lymphadenopathy caused by COVID-19 vaccination takes longer than initially suspected, findings showed, but researchers stressed that mammography should not be delayed.

A two-dose vaccine course is “highly effective” against COVID-19 infection and severe outcomes in patients with rheumatoid arthritis, ankylosing spondylitis, psoriasis and inflammatory bowel disease, according to data.